CK Life Sciences Int'l Inc.

Company Description

CK Life Sciences, listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong in July 2002 (stock code:8222), is engaged in identifying needs and developing revolutionary biotechnology solutions for the improvement of human health and environmental sustainability.We focus on developing patent-protected products that provide new and improved solutions in sustainable land and water use, disease prevention and treatment, nutritional balance and skin care. Our development platform does not involve what is commonly called 'genetic engineering' or 'genetic modification'. Our work primarily involves the application of scientifically advanced methods and processes by which selected microbes, particularly yeasts, with undiscovered potential are activated and acclimatised to perform specific functions in either the human body or the natural environment. Proprietary protection for CK Life Sciences' products, processes and know-how is key to our business. To date, more than 100 product applications have been developed. Our IP (Intellectual Property) portfolio consists of some already approved patents with many others being at different stages of the rigorous patent process in the United States or in other countries through the Patent Cooperation Treaty (PCT) process.